← Back to companies
Amber Bio
0 open3 filled
San Francisco, California, United StatesFounded 202221+ employeesSeed raisedSeedPrivate
Last round: seed · $26M · Aug 2023(1 rounds total)
Founded by Basem Al-Shayeb, Jacob Borrajo
Backed by(7 investors)
Playground GlobalAndreessen HorowitzSV AngelHummingbird VenturesPillar VCRetinal Degeneration FundEli Lilly
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Open Positions at Amber Bio (0 Jobs)
FILLED
Amber Bio
RemoteBusiness & Finance
Associate Director or Director, Nonclinical Development
San Francisco Bay Area Full Time
1 month ago
RemoteBusiness & Finance
1 month agoFILLED
Amber Bio
Research
Research Associate III/ Senior Research Associate (Biodesigner), Assay Development / Bioanalytical Development
San Francisco Bay Area Full Time
6 months ago
Research
6 months agoFILLED
Amber Bio
Research
High-Throughput Screening Research Associate II, III (Biodesigner II, III)
San Francisco Bay Area Full Time
6 months ago
Research
6 months agoReady to start your space career at Amber Bio?
